ISG20 promotes local tumor immunity and contributes to poor survival in human glioma

ISG20 promotes local tumor immunity and contributes to poor survival in human glioma

Recent evidence has confirmed that a mutation of the isocitrate dehydrogenase (IDH) gene occurs early in gliomagenesis and contributes to suppressed immunity. The present study aimed to determine the candidate genes associated with IDH mutation status that could serve as biomarkers of immune suppres...

Full description

Bibliographic Details
Main Authors: Mengqi Gao, Yi Lin, Xing Liu, Yiming Li, Chuanbao Zhang, Zheng Wang, Zhiliang Wang, Yulin Wang, Zongze Guo
Format: Article
Language:English
Published: Taylor & Francis Group 2019-02-01
Series:OncoImmunology
Subjects:
isg20
idh mutation
glioma
prognosis
innate immune response
adaptive immune response
chemokines
pd1/pd-l1
ctla4
rna-seq
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1534038

Internet

http://dx.doi.org/10.1080/2162402X.2018.1534038

Similar Items